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Abstract
Physiologically, the retinal pigment epithelium (RPE) expresses
immunosuppressive signals such as FAS ligand (FASL), which
prevents the accumulation of leukocytes in the subretinal space.
Age-related macular degeneration (AMD) is associated with a
breakdown of the subretinal immunosuppressive environment and
chronic accumulation of mononuclear phagocytes (MPs). We show
that subretinal MPs in AMD patients accumulate on the RPE and
express high levels of APOE. MPs of Cx3cr1/ mice that develop
MP accumulation on the RPE, photoreceptor degeneration, and
increased choroidal neovascularization similarly express high
levels of APOE. ApoE deletion in Cx3cr1/ mice prevents patho-
genic age- and stress-induced subretinal MP accumulation. We
demonstrate that increased APOE levels induce IL-6 in MPs via the
activation of the TLR2-CD14-dependent innate immunity receptor
cluster. IL-6 in turn represses RPE FasL expression and prolongs
subretinal MP survival. This mechanism may account, in part, for
the MP accumulation observed in Cx3cr1/ mice. Our results
underline the inflammatory role of APOE in sterile inflammation in
the immunosuppressive subretinal space. They provide rationale
for the implication of IL-6 in AMD and open avenues toward thera-
pies inhibiting pathogenic chronic inflammation in late AMD.
Keywords age-related macular degeneration; apolipoprotein E; interleukin 6;
mononuclear phagocyte; neuroinflammation
Subject Categories Immunology; Neuroscience
DOI 10.15252/emmm.201404524 | Received 8 August 2014 | Revised 11
December 2014 | Accepted 15 December 2014
Introduction
Age-related macular degeneration (AMD) is the leading cause of
irreversible blindness in the industrialized world (Klein et al, 2004).
Early and intermediate AMD is characterized by sizeable
(> 125 lm) deposits of lipoproteinaceous debris, called large
drusen, which are located in the Bruch’s membrane (BM) and are
partially covered by the retinal pigment epithelium (RPE) (Sarks,
1976). The presence of large drusen is an important risk factor for
late AMD (Klein et al, 2004). There are two clinical forms of late
AMD: wet AMD, which is defined by choroidal neovascularization
(CNV), and geographic atrophy (GA), which is characterized by an
extending lesion of both the retinal pigment epithelium (RPE) and
photoreceptors (Sarks, 1976).
Mononuclear phagocytes (MP) comprise a family of cells that
include microglial cells (MC), monocytes (Mo), and macrophages
(M/) among others (Chow et al, 2011). Physiologically, MCs are
present only in the inner retina. A number of neuron- and glial-
derived factors (e.g., CX3CL1, CD200L) repress their activation
(Galea et al, 2007). The subretinal space, located between the RPE
and the photoreceptor outer segments (POS), is a zone of immune
privilege mediated by immunosuppressive RPE signals, including
leukocyte-suppressing FasL (CD95L) (Griffith et al, 1995; Streilein
et al, 2002). In healthy subjects, the subretinal space is physiologi-
cally devoid of all leukocytes, including MPs, but in both advanced
forms of AMD, wet AMD and geographic atrophy (GA), MPs accu-
mulate in the subretinal space (Oh et al, 1999; Gupta et al, 2003;
Combadiere et al, 2007; Sennlaub et al, 2013). They are in close
contact with the RPE in CNV and in the vicinity of the RPE lesion in
GA (Oh et al, 1999; Gupta et al, 2003; Combadiere et al, 2007;
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Sennlaub et al, 2013). It is generally admitted that MPs play an
important role in CNV (Sakurai et al, 2003; Tsutsumi et al, 2003).
Recent evidence strongly suggests that CCL2/CCR2-dependent
subretinal MP accumulation is an important contributing factor in
photoreceptor degeneration in models of photo-oxidative stress
(Rutar et al, 2012; Suzuki et al, 2012), in the Abca4/Rdh8/
mouse Stargardt/AMD model (Kohno et al, 2013), in the carboxy-
ethylpyrrole immunization-induced AMD model (Cruz-Guilloty
et al, 2013), and in the age- and light-induced photoreceptor degen-
eration of Cx3cr1/ mice (Combadiere et al, 2007; Sennlaub et al,
2013). The reasons for the breakdown of subretinal immuno
suppression and accumulation of MPs in AMD remain unknown.
Apolipoprotein E (APOE) plays a crucial role in lipid transport
(Mahley & Rall, 2000). APOE is expressed in the liver (Linton et al,
1995), is a major component of high-density lipoproteins (HDL) of
the blood (Mahley & Rall, 2000), and is the main lipoprotein of the
brain and the retina (Mahley & Rall, 2000; Anderson et al, 2001).
APOE is also strongly expressed in MCs (Nakai et al, 1996; Peri &
Nusslein-Volhard, 2008) and M/s (Basu et al, 1982; Rosenfeld et al,
1993) and promotes macrophage lipid efflux (Matsuura et al, 2006).
In conjunction with APOA-I, APOE plays a crucial role in reverse
cholesterol transport (Mahley & Rall, 2000). It also binds lipopoly-
saccharide (LPS) (Berbee et al, 2005) and amyloid-b (Zhao et al,
2009) and inhibits their activation of Toll-like receptors (TLR) and
the induction of inflammatory mediators similar to APOA-I (Guo
et al, 2004; Ali et al, 2005). TLR2 and TLR4 signaling necessitates
their recruitment to the CD14-dependent innate immunity receptor
cluster, located in cholesterol-rich membrane domains called lipid
rafts (Schmitz & Orso, 2002). Interestingly, APOA-I and APOE can
also extract membrane cholesterol from lipid rafts, activate the
innate immunity receptor cluster in the absence of TLR ligands, and
induce several inflammatory cytokines including IL-6 (shown for
APOA-I) (Smoak et al, 2010). Recently, it has been shown that
increased IL-6 levels are associated with AMD incidence (Klein et al,
2014) and with late AMD (Seddon et al, 2005; Klein et al, 2008). It
is currently not clear how APOE and IL-6 participate in AMD patho-
genesis.
In humans, APOE exists in three isoforms (APOE2, APOE3, and
APOE4) arising from two cysteine–arginine interchanges at residues
112 and 158. Homozygous APOE2-allele carriers are at increased
risk for developing late AMD (recently confirmed in 20,000 subjects
(McKay et al, 2011)) and are protected against Alzheimer’s disease
(AD), while the APOE4 allele protects against AMD and is a risk
factor for AD (Mahley & Rall, 2000).
The risk-conferring property of the APOE2 allele might be due to
a difference in quantity or result from functional differences of the
APOE2 protein structure. APOE concentrations in plasma and cere-
bro-spinal fluid (CSF) of APOE2 humans and transgenic humanized
mice are significantly higher than in APOE3 carriers (Mooijaart et al,
2006; Riddell et al, 2008). This difference is due to APOE2’s
decreased ability to bind and be cleared via the LDL receptor (Mahley
& Rall, 2000). Consistently increased APOE immunostaining in eyes
with AMD would also suggest that APOE concentrations are locally
increased in AMD (Klaver et al, 1998; Anderson et al, 2001).
On the other hand, ApoE/ mice that are fed a high-fat diet
develop lipid accumulations in BM, which are proposed as being
similar to early AMD (Ong et al, 2001). APOE4 transgenic mice on
high-fat diet develop similar deposits (Malek et al, 2005) even
though the APOE concentration observed in APOE4 transgenic mice
is only marginally decreased in their plasma (Riddell et al, 2008)
and similar in the CSF (Riddell et al, 2008) and retina (Malek et al,
2005) compared to APOE3 mice. The structural changes in the
APOE4 protein, however, lead to diminished association with HDL
(Dong & Weisgraber, 1996) and impaired reverse cholesterol trans-
port (Heeren et al, 2004). Low APOE concentrations or impaired
reverse cholesterol transport could thereby hinder efficient lipid
evacuation from the RPE to the choroid and lead to drusen develop-
ment. (Mahley & Rall, 2000; Mooijaart et al, 2006; Riddell et al,
2008; Malek et al, 2005). This hypothesis is, however, in contradic-
tion with the APOE accumulation observed in AMD donor eyes
(Klaver et al, 1998; Anderson et al, 2001) and the protective effect
of the APOE4 allele in AMD (McKay et al, 2011).
In the present article, we show that subretinal MPs in AMD and
in subretinal inflammation observed in Cx3cr1/ mice strongly
express APOE. We demonstrate that APOE prolongs subretinal MP
survival and is necessary for subretinal MP accumulation in
Cx3cr1/ mice. We demonstrate that increased APOE induces IL-6
in MPs, via the activation of the TLR2-CD14-dependent innate
immune receptor cluster. IL-6 in turn represses RPE FasL expres-
sion, prolongs subretinal MP survival, and promotes chronic subre-
tinal inflammation. Our data suggest that CD14 or IL-6 inhibition
can help reestablish RPE immune-suppressive function and inhibit
pathogenic inflammation in late AMD.
Results
Subretinal MPs accumulate on the RPE in the vicinity of atrophic
lesions and large drusen
Physiologically, the subretinal space does not contain significant
numbers of MPs, possibly due in part to immunosuppressive RPE
signals (Streilein et al, 2002). In late AMD, immunohistochemical
studies on sections revealed the presence of subretinal MPs on RPE
cells adjacent to the lesions of atrophic AMD (Gupta et al, 2003;
Sennlaub et al, 2013) and MPs are found in subretinal neovascular
membranes (Oh et al, 1999). Because the small, dispersed MPs are
difficult to detect on sections, we performed MP marker IBA-1
immunohistochemistry on healthy and diseased macular RPE/
choroidal flatmounts (IBA-1 green fluorescence, RPE autofluorescence
visible as orange due to its autofluorescence in the red and green
channel). Confocal microscopy confirmed that subretinal IBA-1+
MPs are only very occasionally observed in healthy age-matched
donor central RPE (Fig 1A). Within the atrophic lesions of GA
patients where the RPE has disappeared, MPs were numerous, but
were also invariably observed on the apical side of the RPE adjacent
to the lesions (Fig 1B). Furthermore, IBA-1+ cells were detected on
the RPE adjacent to large drusen (> 125 lm), visible under the
dissecting microscope as pale lesions after removal of the retina
(Fig 1C, inset) and as dome-shaped protrusions under the confocal
microscope (Fig 1C, oblique projection of a Z-stack; Fig 1D, orthog-
onal Z-stack projection). Double-labeling on the subretinal side of
the overlaying retina (to avoid masking by RPE autofluorescence)
shows that subretinal IBA-1+ MPs (Fig 1E green fluorescence) also
express the pan-MP marker CD18 (Fig 1F red fluorescence, Fig 1G
merge). IBA-1+ MPs in close contact with the RPE (Fig 1H, lateral
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Z-stack projections) were observed in the vicinity of all examined
large drusen and atrophic zones. Interestingly, we also detected
IBA-1+ MPs within the large drusen, confirming our previous
immunohistochemical detection of CCR2+ MPs on paraffin sections
within large drusen (Sennlaub et al, 2013). HLA-DR and CD68-
positive MP dendrites have previously been observed in smaller,
dome-shaped drusen (Hageman et al, 2001). A detailed analysis of
MPs within drusen of different sizes is ongoing in our laboratory,
but beyond the scope of this study.
These observations considered together confirm the presence of
subretinal MPs in AMD (Penfold et al, 1985; Gupta et al, 2003;
Sennlaub et al, 2013) and illustrate their presence in contact with
the RPE around large drusen and GA lesions. They are very rare in
healthy donors. This further suggests that RPE-mediated immuno-
suppression is impaired in intermediate AMD (large drusen) and
late AMD (GA).
Subretinal MPs express APOE
MPs have been reported to express APOE at high levels (Basu et al,
1982; Rosenfeld et al, 1993; Nakai et al, 1996; Peri & Nusslein-
Volhard, 2008). Immunohistochemistry of APOE (Fig 2A, red) and
IBA-1 (Fig 2B, green; Fig 2C, merge) on paraffin sections of human
tonsils, which we used as a positive control, confirmed that IBA-1+
MPs can strongly express APOE. Similarly, on retinal flatmounts of
donor eyes with large drusen, APOE (Fig 2D, red) staining was
observed in and around subretinal IBA-1+ MPs (Fig 2E, green; Fig
2F, merge). The double-labeling was performed on the subretinal
side of retinas to avoid masking by the RPE autofluorescence. We
next performed APOE staining on paraffin sections of controls and
donor eyes with geographic atrophy lesions. We used a substrate
revealing method (alkaline phosphatase/Fast Red) that is visible in
bright field to circumvent confusion with RPE autofluorescence. In
sections from control eyes, the APOE signal was concentrated at the
basal portion of the RPE (Fig 2G red signal, arrows). In donor eyes
with GA, adjacent to the atrophic area, a strong APOE signal was
observed in the RPE, but it was less restricted to the basal aspect
than in controls (Fig 2H APOE red signal, arrowheads). Addition-
ally, APOE immunostaining was observed in cells adjacent to the
RPE (Fig 2H APOE red signal, arrows). Double-labeling with IBA-1
identified these cells as subretinal IBA-1+ MPs (Fig 2I IBA-1 green
signal, arrows). Omitting the APOE antibody and following the same
experimental protocol did not produce any significant staining
(Fig 2H inset).
Taken together, our results show that, in addition to the RPE,
subretinal MPs in AMD patients strongly express APOE in a manner
similar to other inflammatory settings (e.g., atherosclerotic lesions
(Rosenfeld et al, 1993)).
APOE promotes subretinal MP accumulation in
Cx3cr1GFP/GFP mice
In the eye, CX3CL1 is constitutively expressed as a transmembrane
protein in inner retinal neurons (Silverman et al, 2003; Zieger et al,
2014) and provides a tonic inhibitory signal to CX3CR1 bearing reti-
nal MCs that keeps these cells in a quiescent surveillance mode
under physiological conditions (Combadiere et al, 2007; Ransohoff,
2009). Cx3cr1 deficiency in mice leads to a strong increase of subre-
tinal MP accumulation with age, after light challenge or laser injury
(Combadiere et al, 2007; Raoul et al, 2008; Ma et al, 2009), in
A B C D
E F G H
Figure 1. Subretinal MPs accumulate on the retinal pigment epithelium in AMD.
A–D Confocal microscopy of IBA-1 (green staining) immunohistochemistry of RPE flatmounts (RPE autofluorescence visible as orange due to its autofluorescence in the
red and green channel) from a healthy donor (A), a geographic atrophy lesion (B), and large drusen (C and D). (A, B, D): orthogonal Z-stack projection; (C): oblique
Z-stack projection and dissecting microscope appearance of postmortem large drusen after removal of the overlaying retina (inset).
E–G Double-labeling on the subretinal side of the retina (to avoid masking by RPE autofluorescence) of IBA-1+ (E, green fluorescence) and CD18 (F, red fluorescence;
G, merge).
H Orthogonal and lateral Z-stack of a subretinal IBA-1+ (green fluorescence) MPs adjacent to the RPE (orange autofluorescence) in the vicinity of a large drusen.
Data information: Controls omitting the primary antibody showed no staining apart from the autofluorescence. AZ: atrophic zone; LD: large drusen. Scale bar: 50 lm
(A–D); 10 lm (E–H).
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diabetes (Kezic et al, 2013) and in a paraquat-induced retinopathy
model (Chen et al, 2013). Cx3cr1GFP/GFP mice do not develop drusen
and RPE atrophy, but do model MP accumulation on the RPE, as
well as the associated photoreceptor degeneration and excessive
CNV observed in AMD (Combadiere et al, 2007; Sennlaub et al,
2013).
We first evaluated APOE localization in 12-month-old Cx3cr1GFP/GFP
mice that present subretinal MP accumulation (Sennlaub et al,
2013). Immunohistochemical localization of APOE on retinal
sections of both 12-month-old wild-type and Cx3cr1GFP/GFP mice
revealed APOE localization mainly in the RPE and inner retina as
previously described (Anderson et al, 2001) (Supplementary Fig S1).
Additionally, we detected a strong signal in cells apposed to the RPE
on retinal sections and the subretinal side of retinal flatmounts in
aged Cx3cr1GFP/GFP mice (arrow, Fig 3A and B, red) that were identi-
fied as IBA-1-expressing MPs (Fig 3C, green), similar to AMD
patients (Fig 1).
Subretinal MPs are derived from both Mos and MCs (Sennlaub
et al, 2013). To evaluate whether Cx3cr1GFP/GFP MPs differ in their
ApoE expression, we first studied WT- and Cx3cr1GFP/GFP-Mo
(prepared from bone marrow) cultured for 24 h in contact with the
photoreceptor outer segment (POS) of an overlaying retinal explant
to simulate MP differentiation in the subretinal space. ApoE mRNA
was expressed at significantly higher levels in Cx3cr1GFP/GFP-Mos in
the presence of POS of an overlaying retinal explant (Fig 3D). Simi-
larly, significantly increased amounts of ApoE mRNA were also
observed in FACS-sorted MCs freshly extracted from adult
Cx3cr1GFP/GFP brain (Fig 3E). The expression of ApoE mRNA was
also significantly higher in Cx3cr1GFP/GFP peritoneal M/s (prepared
from thioglycollate-elicited peritonitis) when compared to WT-M/s
cultured for 24 h in the presence of CX3CL1 (Fig 3F). Western blot
analysis of equivalent amounts of supernatant protein from perito-
neal M/s also showed increased APOE secretion (Fig 3G) in the
Cx3cr1GFP/GFP samples when compared to the soluble Mer receptor
tyrosine kinase that is released constitutively from cultured macro-
phages (Sather et al, 2007) and which served here as a loading
control.
To evaluate the role of APOE in subretinal MP accumulation, we
analyzed Cx3cr1GFP/GFP ApoE/ mice. Quantification of subretinal
IBA-1+ MPs on retinal and RPE/choroidal flatmounts of 12-month-
old Cx3cr1GFP/GFP (Fig 3H) and Cx3cr1GFP/GFP ApoE/ mice (Fig 2I)
showed that the significant age-dependent subretinal MP accumula-
tion observed in Cx3cr1GFP/GFP mice was nearly completely inhibited




Figure 2. Subretinal MPs express APOE.
A–C APOE (A) and IBA-1 (B, merge in C) double-labeling on paraffin sections of surgical specimens of human tonsils.
D–F APOE (D) and IBA-1 (E, merge in F) double-labeling on the subretinal aspect of a large drusen overlaying retina (to avoid specific signal masking by the RPE orange
autofluorescence).
G, H APOE (red staining) immunohistochemistry of control donor tissue (G) and adjacent to GA lesion (H).
I IBA-1 (green staining, RPE far-red autofluorescence) double-labeling of the GA lesion shown in (H). Representative images from five donor eyes with large drusen,
five donor eyes with GA, and three healthy donors between 70 and 89 years old.
Data information: Controls omitting the primary antibody showed no staining apart from the autofluorescence (H inset). ONL: outer nuclear layer; INL: inner nuclear
layer; Ch: choroid. Scale bar: 10 lm.
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Figure 3. APOE promotes subretinal MP accumulation in Cx3cr1GFP/GFP mice.
A–C Immunohistochemistry of APOE (red) and IBA-1 (green) on a section (A, blue Hoechst) and the subretinal side of a retinal flatmount (B and C) from a 12-month-old
Cx3cr1GFP/GFP mouse (representative of 3 independent experiments, experiments omitting the primary antibody immunostaining served as negative controls). ONL:
outer nuclear layer; RPE: retinal pigment epithelium.
D Quantitative RT–PCR of ApoE mRNA normalized with S26 mRNA of C57BL/6J and Cx3cr1GFP/GFP monocytes cultured for 24 h in contact with POS of an overlaying
retinal explant (n = 4/group per experiment; Mann–Whitney U-test, *P = 0.0286, the experiment was repeated twice with similar results).
E Quantitative RT–PCR of ApoE mRNA normalized with S26 mRNA of C57BL/6J and Cx3cr1GFP/GFP FACS-sorted microglial cells, freshly extracted from adult brain
(n = 4–5/group; Mann–Whitney U-test, C57BL/6J versus Cx3cr1GFP/GFP *P = 0.0159).
F Quantitative RT–PCR of ApoE mRNA normalized with S26 mRNA of C57BL/6J and Cx3cr1GFP/GFP peritoneal macrophages cultured for 24 h with CX3CL1. (n = 4/group
per experiment; Mann–Whitney U-test, *P = 0.0286. The experiment was repeated twice with similar results).
G APOE Western blot analysis of equivalent amounts of supernatant protein from CX3CL1-exposed C57BL/6J and Cx3cr1GFP/GFP peritoneal macrophages at 24 h.
Soluble Mer receptor tyrosine kinase that is released constitutively from cultured macrophages served as a loading control. The experiment was repeated twice
with similar results.
H, I 12-month-old IBA-1 stained RPE flatmounts of Cx3cr1GFP/GFP (H) and Cx3cr1GFP/GFPApoE/ (I) mice.
J Quantification of subretinal IBA-1+ mononuclear phagocytes in 2-month-old (left) and 12-month-old (right) mice of the indicated strains (n = 9–20/group ANOVA/
Dunnett test at 12 months: Cx3cr1GFP/GFP versus any other group *P < 0.0001; Mann–Whitney U-test at 12 months of Cx3cr1GFP/GFP versus Cx3cr1GFP/GFPApoE/
*P < 0.0001).
K Quantification of subretinal IBA-1+ mononuclear phagocytes after 4 days of light challenge of 2-month-old mice of the indicated strains (n = 10–25/group ANOVA/
Dunnett test: Cx3cr1GFP/GFP versus any other group *P < 0.0001; Mann–Whitney U-test of Cx3cr1GFP/GFP versus Cx3cr1GFP/GFPApoE/ *P < 0.0001).
L, M IBA-1- (green) and CD102- (red) stained RPE flatmounts 7 days after laser injury of 2-month-old Cx3cr1GFP/GFP (E) and Cx3cr1GFP/GFPApoE/ (F) mice.
N Quantification of subretinal IBA-1+ mononuclear phagocytes on the RPE counted on the RPE at a distance of 0–500 lm to CD102+ CNV 7 days after the laser
injury of 2-month-old mice of the indicated strains (n = 8–10 eyes/group ANOVA/Dunnett test: Cx3cr1GFP/GFP versus any other group *P < 0.0001; Mann–Whitney
U-test of Cx3cr1GFP/GFP versus Cx3cr1GFP/GFPApoE/ *P < 0.0001).
Data information: +R: cultured with an overlying retinal explant. Scale bars, 50 lm.
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ApoE/ mice were significantly protected against the subretinal MP
accumulation observed in Cx3cr1GFP/GFP mice after 4 days of light
challenge (Fig 3K). It should be noted that the intensity of the light
challenge model used herein is sufficient to induce subretinal
inflammation in the Cx3cr1/ mice but does not cause significant
subretinal inflammation nor degeneration in WT mice (Sennlaub
et al, 2013). Moreover, 7 days after a laser impact, subretinal IBA-1+
MPs (green staining) counted on the RPE at a distance of 0–500 lm
to CD102+ CNV (red staining) in Cx3cr1GFP/GFP (Fig 3L) and
Cx3cr1GFP/GFP ApoE/ mice (Fig 3M) were significantly inhibited
in Cx3cr1GFP/GFP ApoE/ mice (Fig 2N). Additionally, ApoE deletion
also significantly inhibited the age-dependent photoreceptor
degeneration and exaggerated CNV observed in Cx3cr1GFP/GFP mice
(Supplementary Figs S2 and S3).
C57BL/6 mice are inbred and can carry Pde6brd1 (retinal degen-
eration 1), Crb1rd8 (retinal degeneration 8), and Gnat2cpfl3 (Cone
photoreceptor function loss 3) mutations relatively commonly
(Chang et al, 2013). These mutations can lead to subretinal
inflammation secondary to primary retinal degeneration (Luhmann
et al, 2012). In our experiments, all mice strains used tested nega-
tive for these three mutations. Furthermore, subretinal MP accu-
mulation in 12-month-old Cx3cr1+/GFP and Cx3cr1GFP/GFP littermates
of Cx3cr1+/GFP breeders showed no evidence of influence from an
unknown contributor gene specific to the Cx3cr1GFP/GFP mouse line
(Supplementary Fig S4). Cx3cr1GFP/GFP ApoE/ mice were gener-
ated twice with independently purchased Cx3cr1GFP/GFP and
ApoE/ mice (once at the Laboratoire Immunite´ et Infection and
once at the Institut de la Vision), and both Cx3cr1GFP/GFP ApoE/
mice strain generations were protected against the subretinal MP
accumulation observed in the two Cx3cr1GFP/GFP mouse strains of
the two sites. Taken together, these results make it highly unlikely
that the MP accumulation in Cx3cr1GFP/GFP mice and the protection
in Cx3cr1GFP/GFP ApoE/ mice are due to genes other than Cx3cr1
and ApoE.
In summary, we show that APOE is robustly expressed in subre-
tinal MPs, more strongly expressed in Cx3cr1GFP/GFP MPs, and that
ApoE deletion very significantly inhibited the age-, light-, and laser-
induced accumulation of subretinal MPs observed in Cx3cr1-
deficient mice.
APOE inhibits subretinal MP clearance
The reasons for which subretinal MPs accumulate in Cx3cr1-
deficient mice are not fully understood. Theoretically, the numbers
of subretinal MPs are determined by (i) recruitment, (ii) in situ
proliferation, (iii) migration (egress), and/or (iv) apoptotic clear-
ance. We previously showed that Cx3cr1GFP/GFP MPs overexpress
CCL2, which in turn leads to increased CCR2+ Mos recruitment
from the blood. This in part explains the accumulation of MPs in
Cx3cr1-deficient mice (Sennlaub et al, 2013). Local injections of the
traceable nucleotide EdU in light-challenged Cx3cr1GFP/GFP mice
failed to be incorporated in subretinal MPs, suggesting that in situ
proliferation does not significantly contribute to the accumulation
(Supplementary material of (Sennlaub et al, 2013)). To evaluate
whether subretinal MPs egress from the subretinal space or undergo
apoptosis, we adoptively transferred 12,000 CFSE-stained WT and
Cx3cr1GFP/GFP thioglycollate-elicited peritoneal cells (containing 70%
M/s) in the subretinal space of WT mice (Fig 4A, 12 h) and
counted the number of F4/80-expressing M/s that co-stained for
CFSE on RPE and retinal flatmounts once retinal detachment had
subsided (8–12 h). Quantifications show that injected CFSE+ M/s
of both genotypes were cleared from the subretinal space over a
period of 4 days, but that Cx3cr1GFP/GFP-M/ clearance was signifi-
cantly slower and that Cx3cr1GFP/GFP-M/s subsisted in significantly
higher numbers at one and two days (Fig 4B). We detected no signs
of egress from the subretinal space in WT or Cx3cr1GFP/GFP-M/-
injected animals, as no CFSE+ cells were observed in the inner
retina, choroid, blood, local lymph nodes, lung, liver, or spleen by
histology or cytometry (data not shown). However, the nuclei of a
large number of subretinal CFSE+ M/s of both genotypes were
TUNEL+ (Fig 4C, TUNEL stained (red) CFSE+ (green) WT-M/s)
and displayed signs of apoptosis (Fig 4C, inset: pyknotic and frag-
mented nuclei). These results suggest that subretinal M/ clearance
is predominantly mediated by apoptosis, in accordance with obser-
vations of inflammation resolution in peripheral tissue (Gautier
et al, 2013) and in particular with leukocyte clearance in the
context of the subretinal immunosuppressive environment (Streilein
et al, 2002).
Cytometric quantification of CFSE+F4/80+CD11b+-M/s in eye
cell suspensions from injected eyes confirmed that Cx3cr1GFP/GFP-M/s
were present in significantly higher numbers when compared to
WT-M/s 1 day after adoptive transfer (Fig 4D, the GFP fluorescence
did not interfere with the several log stronger CFSE signal in the
cytometric analysis). The CFSE fluorescence intensity of the
F4/80+CD11b+-M/s in the cytometric analysis was strong and
homogeneous (Fig 4D), suggesting that CFSE uptake by host cells
(which leads to variable CFSE intensities) or proliferation (which
leads to cell populations with halved CFSE fluorescence intensity)
did not occur to a significant degree. Furthermore, WT- and
Cx3cr1GFP/GFP-M/s did not reveal differences in proliferation in vitro
(Supplementary Fig S5), suggesting that fast proliferation of
Cx3cr1GFP/GFP-M/s does not account for the observed difference in
the adoptive transfer experiments.
We next evaluated whether the observed differences were
specific to peritoneal M/s or shared by MPs of other origins. We
adoptively transferred CFSE-labeled, magnetic-bead-sorted bone
marrow-derived Mos (~95% pure, Fig 4E) and CD11b FACS-sorted
brain MCs (~95% pure, Fig 4F) from WT and Cx3cr1GFP/GFP mice
into the subretinal space of WT mice. As with peritoneal M/s,
Cx3cr1-deficient MPs of both origins were significantly greater in
number when counted on retinal and RPE/choroidal flatmounts
1 day after the injections.
To evaluate whether MP APOE expression influences the rate of
subretinal MP clearance, we adoptively transferred Cx3cr1GFP/GFP
ApoE/-M/s into WT recipients. Strikingly, the increased resis-
tance to subretinal clearance of Cx3cr1GFP/GFP-M/s was completely
eliminated with Cx3cr1GFP/GFP ApoE/-M/s (Fig 4G). Furthermore,
exogenous lipid-free APOE3, the predominant human APOE
isoform, was sufficient to increase resistance to subretinal clearance
when added to WT-CFSE+-M/s (Fig 4H).
Taken together, our results show that Cx3cr1-deficient MPs of all
origins studied (peritoneum, bone marrow, and brain) are more
resistant to subretinal clearance. We show that this increase of
resistance to clearance is APOE dependent and that local, recombi-
nant APOE is sufficient to inhibit WT-M/s elimination from the
subretinal space.
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Figure 4. APOE inhibits subretinal MP clearance.
A Representative image of a RPE flatmount 12 h after the subretinal injection (red marking) of 4 ll PBS with 12,000 CFSE-stained thioglycollate-elicited peritoneal cells
that contain 70% macrophages (inset close-up view).
B Quantifications of CFSE+F4/80+ macrophages at different time points after subretinal injections of C57BL/6J and Cx3cr1GFP/GFP CFSE+ macrophages (n = 5/per group
(12 h) and n = 6/per group thereafter; Mann–Whitney U-test, C57BL/6J versus Cx3cr1GFP/GFP: 1 day n = 20/group *P < 0.0001; 2 day n = 6/group *P = 0.0317).
C Representative image of TUNEL/Hoechst double-staining 12 h after subretinal injection of C57BL/6J CFSE+ macrophages (experiment repeated three times, inset
close-up view).
D Representative cytometry images of SSC-A/CFSE and CD11b/F4/80 gated analysis of eye cell suspensions prepared 24 h after the injection of Cx3cr1GFP/GFP CFSE+
macrophages and cytometric quantification of eye cell suspensions at 24 h after the injection of C57BL/6J and Cx3cr1GFP/GFP macrophages into C57BL/6J (n = 16–20/
group; Mann–Whitney U-test, *P = 0.0024).
E Quantification of subretinal CFSE+ cells on RPE and retinal flatmounts 24 h after subretinal injections of CFSE+ magnetic-bead-sorted bone marrow-derived
monocytes (Mo) from C57BL/6J and Cx3cr1GFP/GFP mice into C57BL/6J mice (n = 8–12/group; Mann–Whitney U-test, *P = 0.0006).
F Quantification of subretinal CFSE+ cells on RPE and retinal flatmounts 24 h after subretinal injections of CFSE+CD11b FACS-sorted brain microglial cells from
C57BL/6J and Cx3cr1GFP/GFP mice into C57BL/6J mice (n = 9–12/group; Mann–Whitney U-test, *P = 0.0087).
G Quantification of subretinal CFSE+F4/80+ macrophages on RPE and retinal flatmounts 24 h after subretinal injections of CFSE+ macrophages from C57BL/6J,
Cx3cr1GFP/GFP, Cx3cr1GFP/GFPApoE/, and ApoE/ mice into C57BL/6J mice (n = 8–12/group; one-way ANOVA/Dunnett test of Cx3cr1GFP/GFP versus any other group
*P ≤ 0.0001; Mann–Whitney U-test, Cx3cr1GFP/GFP versus Cx3cr1GFP/GFPApoE/ *P = 0.0006).
H Quantification of subretinal CFSE+F4/80+ macrophages on RPE and retinal flatmounts 24 h after subretinal injections of C57BL/6J CFSE+ macrophages into C57BL/6J
and with exogenously added APOE3 at 1, 10, or 100 lg/ml calculated intraocular concentrations (n = 6–7/group; one-way ANOVA/Dunnett test: C57BL/6J versus
10 lg *P = 0.0488; C57BL/6J versus 100 lg ‡P = 0.006. Mann–Whitney U-test: C57BL/6J versus 10 lg *P = 0.0012; C57BL/6J versus 100 lg ‡P = 0.0013).
Data information: All primary cells were prepared from male mice; all recipient C57BL/6J mice were male. Mo: monocytes; MC: microglial cells; M/: macrophages; SCC-A:
side scatter detector A. Scale bars: 1 mm (A); 50 lm (C).
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FAS-FASL signaling mediates subretinal MP clearance
The RPE constitutively expresses FASL (CD95L), which in part medi-
ates its immunosuppressiveness (Wenkel & Streilein, 2000). To test
whether an alteration of the RPE immunosuppressive environment is
associated with subretinal Cx3cr1GFP/GFP-MP accumulation, we first
analyzed FasL expression in vivo. FasL mRNA was similarly
expressed in 2-month-old WT and Cx3cr1GFP/GFP mouse RPE/choroidal
plexus, before significant subretinal MP accumulation occurred in
Cx3cr1GFP/GFP mice. In contrast, 12-month-old Cx3cr1GFP/GFP mice
and 2-month-old light-challenged Cx3cr1GFP/GFP mice with subretinal








Figure 5. FAS-FASL signaling mediates subretinal MP clearance.
A Quantitative RT–PCR of FasL mRNA normalized with b-actin mRNA of 2-month-, 12-month-, and 2-month-old mice after 4 days of light challenge of C57BL/6 and
Cx3cr1GFP/GFP mouse RPE/choroid plexus (aging: n = 5–6/group; Mann–Whitney U-test: 12 months *P = 0.0129; 4 days light challenge: n = 7–8/group; *P = 0.029).
B, C Immunohistochemistry of FASL (red) and IBA-1 (green) of a RPE flatmounts and sections (insets, Hoechst staining blue) from a 12-month-old WT (B) and
Cx3cr1GFP/GFP(C) mouse (representative of three independent experiments, immunostainings omitting the primary antibody served as negative controls).
D Quantitative RT–PCR of FasL mRNA normalized with b-actin mRNA of 12-month-old C57BL/6 RPE/choroid plexus extracts 3 h after subretinal injection of C57BL/6J
macrophages or Cx3cr1GFP/GFP macrophages (n = 6 per group), Mann–Whitney U-test, *P = 0.0087.
E–G IBA-1-stained RPE flatmounts of 2-month-old C57BL/6J, Faslgld/gld, and Faslpr/lpr mice after 4 days of light challenge.
H Quantification of subretinal IBA-1+ mononuclear phagocytes in control (left) and 4-day light-challenged (right) 2-month-old mice of the indicated strains
(n = 6–10/group ANOVA/Dunnett test at 4-day light challenge: C57BL/6J versus FasLgld/gld and C57BL/6J versus Faslpr/lpr both *P < 0.0001; Mann–Whitney U-test at
4-day light challenge: C57BL/6J versus FasLgld/gld *P < 0.0001; C57BL/6J versus Faslpr/lpr *P < 0.0001).
I Quantification of subretinal CFSE+F4/80+ macrophages on RPE and retinal flatmounts 24 h after subretinal injection of C57BL/6J CFSE+ macrophages into C57BL/6J
and FasLgld/gld mice and Faslpr/lpr macrophages into C57BL/6J mice (n = 10–15/group, one-way ANOVA/Dunnett test: C57BL/6J macrophages inj. into C57BL/6J mice
versus C57BL/6J macrophages inj. into Fasgld/gld mice *P = 0.0002; C57BL/6J macrophages inj. into C57BL/6J mice versus Faslpr/lpr macrophages inj. into C57BL/6J mice
*P < 0.0001. Mann–Whitney U-test: C57BL/6J macrophages inj. into C57BL/6J mice versus C57BL/6J macrophages inj. into FasLgld/gld mice *P < 0.0001; C57BL/6J
macrophages inj. into C57BL/6J mice versus Faslpr/lpr macrophages inj. into C57BL/6J mice *P < 0.0001).
J Quantification of subretinal CFSE+F4/80+ macrophages on RPE and retinal flatmounts 24 h after subretinal injection of Cx3cr1GFP/GFP CFSE+ macrophages into
C57BL/6J with or without the Fas agonist MegaFasL (calculated intraocular concentrations 1 ng/ml; n = 7–8; Mann–Whitney U-test: *P = 0.014).
K In vitro MegaFasL-induced apoptosis of monocytes and macrophages of the indicated genotypes cultured for 24 h. TUNEL+ nucleus quantification expressed as
percentage of non-MegaFasL-exposed control.
Data information: All primary cells were prepared from male mice; all recipient C57BL/6J or FasLgld/gld mice were male. Mo: monocytes; MΦ: macrophages. Scale bars:
20 lm (B, C); 50 lm (E–G).
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RT–PCR) as compared to WT. Immunohistochemistry on retinal
sections and RPE flatmounts of WT and Cx3cr1GFP/GFP mice (Fig 5B
and C, FasL, red; IBA-1, green) seemed to confirm the diminished
FASL expression in the RPE of Cx3cr1GFP/GFP mice at 12 months.
These results might suggest that Cx3cr1-deficient MPs some-
how inhibit RPE FasL transcription. Indeed, when we injected
Cx3cr1GFP/GFP-M/s into the subretinal space of WT mice, FasL tran-
scription on RPE/choroidal extracts was significantly inhibited after
3 h, when compared to WT-M/s-injected eyes (Fig 5D, RT–PCR).
To evaluate whether FAS-FASL signaling participates in MP
clearance, we first compared subretinal MP numbers in light-
challenged WT (Fig 5E), FASL-defective (FasLgld/gld mice, Fig 5F), and
FAS-defective (Faslpr/lpr mice, Fig 5G) mice (FasLgld/gld and Faslpr/lpr
mice develop lymphadenopathy and systemic autoimmune disease
with age, making it difficult to evaluate age-dependent MP accumu-
lation at 12 months). Quantification of subretinal IBA-1+ MPs on
retinal and RPE/choroidal flatmounts revealed a significant increase
of subretinal MPs in 2-month-old FasLgld/gld and Faslpr/lpr mice
induced by 4 days of light challenge (Fig 5H), similar to that of
Cx3cr1GFP/GFP mice (Fig 3). Moreover, adoptive transfer experiments
in which we subretinally injected thioglycollate-elicited WT-CFSE+-
M/s into WT or FasL-defective mice (FasLgld/gld mice), and
Fas-defective CFSE+ M/s (prepared from thioglycollate-elicited
peritonitis of Faslpr/lpr mice) into WT mice, revealed that subretinal
CFSE+F4/80+-M/s were significantly greater in number 24 h after
the injection when FAS or FASL function was impaired (Fig 5I) and
comparable to the phenotype observed in Cx3cr1GFP/GFP M/s (Fig 3).
In addition, co-administration of FAS agonist MegaFasL (Greaney
et al, 2006) to Cx3cr1GFP/GFP M/s efficiently compensated for the
observed FasL downregulation (Fig 5D) and significantly reduced
the number of subretinal Cx3cr1GFP/GFP CFSE+F4/80+-M/s after
adoptive transfer (Fig 5J).
To test whether differences in the susceptibility to FASL-
induced MP death might contribute to the protective effect of
ApoE deletion in subretinal MP accumulation, we exposed Mos
and thioglycollate-elicited M/s from the different mouse strains to
MegaFasL and quantified TUNEL+ cells at 24 h in vitro (Fig 5K).
Our results confirm previous reports that FASL is sufficient to
induce Mos apoptosis in vitro in comparison with M/s, which are
rather resistant to FASL-induced apoptosis in vitro (Um et al,
1996; Kiener et al, 1997; Park et al, 2003). We did not observe a
difference between wild-type and Cx3cr1GFP/GFP cells of either Mos
or M/s, but a tendency toward increased susceptibility in Mos of
both Cx3cr1GFP/GFP ApoE/ and ApoE/ cells, which might
contribute toward the differences in clearance observed in vivo
(Fig 3). These results also highlight that FASL acts along with
other factors in vivo to induce M/ apoptosis in the subretinal
space, as the effect of MegaFasL on subretinal clearance of adop-
tively transferred peritoneal M/s (Fig 5J) was much stronger than
MegaFasL-induced apoptosis in vitro (Fig 5K). Similarly, a syner-
gistic effect of FasL with other RPE-derived factors has been
suggested by the observations that FASL is necessary to eliminate
T cells and M/s and prevent RPE allograft rejection (Wenkel &
Streilein, 2000), but FASL over-expression alone in an allograft,
such as a Langerhans cell graft, is not sufficient to prevent rejec-
tion (Kang et al, 1997).
Taken together, our data show that FAS-FASL signaling is impli-
cated in subretinal MP clearance, that subretinal Cx3cr1GFP/GFP MPs
are associated with a downregulation of RPE FASL expression, and
that substitution by MegaFasL restores, in part, the clearance of
subretinal Cx3cr1GFP/GFP MPs.
APOE promotes subretinal macrophage survival via IL-6
Our results show that the increased survival of Cx3cr1GFP/GFP-M/s is
associated with diminished RPE FasL transcription, which plays a
role in subretinal MP clearance (Fig 4). Furthermore, APOE, over-
expressed by Cx3cr1GFP/GFP-M/s or exogenously added to WT-M/s,
increases subretinal M/s survival (Fig 3). However, subretinal
injections of recombinant APOE without M/s (at a concentration
that increases subretinal MP survival (Fig 3H) and compared to
PBS-injected eyes) did not replicate the observed FasL downregula-
tion in RPE/choroid (Fig 6A, RT–PCR 3 h after injection), which we
observed after adoptive transfer of Cx3cr1GFP/GFP-M/s (Fig 5D).
These results suggest that APOE does not directly influence RPE
FasL expression. However, recombinant IL-6, shown to downregu-
late FasL expression in lymphocytes (Ayroldi et al, 1998), was suffi-
cient to significantly inhibit RPE FasL transcription in this
experimental setting (Fig 6A). APOE and APOA-I can both activate
the CD14-dependent innate immunity receptor cluster that contains
TLR-2 and TLR-4 in the absence of TLR ligands (Smoak et al, 2010).
This activation has been shown to induce IL-6, among other cyto-
kines, in the case of APOA-I. Similarly, when we incubated WT-
peritoneal-M/s with recombinant lipid-free APOE3 for 24 h, IL-6 was
very significantly induced (Fig 6B). The LPS inhibitor polymyxin B
did not inhibit the induction, while 90-min heat denaturation abol-
ished the induction, confirming that LPS contamination of APOE3 is
not accountable for the effect, as shown for APOA-I using multiple
approaches (Smoak et al, 2010). As previously shown for APOA-I,
this induction was largely CD14 and TLR2 dependent, as neutraliz-
ing antibodies inhibited this effect, when compared to a control IgG
(Fig 6B). Correspondingly, Cx3cr1GFP/GFP-M/s expressed signifi-
cantly higher amounts of IL-6 mRNA when compared to WT-M/s
cultured for 24 h. This effect was significantly inhibited in
Cx3cr1GFP/GFP ApoE/-M/s (Fig 6C), confirming the involvement of
APOE. Although IL-6 was not detectable by RT–PCR in whole-eye
mRNA extracts in vivo, IL-6 staining (Fig 6D, red) was reproducibly
detected in subretinal IBA-1+-MPs (Fig 6E, green) adjacent to the
phalloidin+RPE (Fig 6E, blue, orthogonal, and lateral Z-stack projec-
tions of a confocal microscopy picture stack) of 12-month-old
Cx3cr1GFP/GFP mice and light-challenged Cx3cr1GFP/GFP mice (data not
shown).
In addition, recombinant IL-6 added to WT-CFSE+M/s more
than doubled the number of subretinal CFSE+F4/80+-M/s (Fig 6F)
and an IL-6-blocking antibody significantly decreased subretinal
Cx3cr1GFP/GFPCFSE+F4/80+-M/s (Fig 6G) 24 h after injection when
compared to their controls.
When taken together, the results presented in Figs 2–5 suggest
the following mechanism: Cx3cr1GFP/GFP MPs express increased
amounts of APOE. APOE induces the expression of IL-6 in MPs,
which in turn downregulates FasL transcription in the RPE. The
diminished FASL expression participates in the increased survival
time of subretinal Cx3cr1GFP/GFP MPs (Fig 6H).
Finally, to test whether CD14-dependent IL-6 induction does
indeed participate in subretinal MP accumulation in vivo, we
injected control IgG (Fig 6I), an IL-6- (Fig 6J) or CD14-neutralizing
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antibody into the vitreous of Cx3cr1GFP/GFP mice and induced subre-
tinal inflammation with a laser injury (which also facilitates anti-
body penetration into the subretinal space). Our results show that
the accumulation of subretinal IBA-1+ MPs (green staining)
observed on the RPE adjacent to CD102+ CNV (red staining), 7 days
after a laser impact, was significantly inhibited when CD14 or IL-6
was neutralized, as was the associated CNV (Supplementary
Fig S6).
Discussion
MPs are activated and accumulate in wet AMD (Oh et al, 1999) and
around the atrophic lesions of GA adjacent to the RPE (Combadiere
et al, 2007; Sennlaub et al, 2013). Our findings of numerous
subretinal MPs in and around large drusen and GA lesions
illustrate the significant focal inflammation that is present in AMD.
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immunosuppressive properties of the RPE (Streilein et al, 2002)
are altered in the disease. We show that subretinal MPs, in addi-
tion to the RPE, express high levels of APOE similar to MPs in
other inflammatory conditions (Rosenfeld et al, 1993).
Using Cx3cr1GFP/GFP mice as a model of subretinal inflammation,
we show that increased expression of APOE, observed in
Cx3cr1GFP/GFP MPs, is associated with significant acute (laser- and
light-induced) and chronic (age-dependent) subretinal MP accumu-
lation. The observation that Cx3cr1-deficient M/s are cleared less
efficiently from the subretinal space of WT mice suggests that the
in vivo accumulation is at least in part due to the capacity of
Cx3cr1-deficient M/s to inhibit the RPE immunosuppression and
prolong their survival when compared to WT-M/s. Using
Cx3cr1GFP/GFP ApoE/-M/s and recombinant APOE, we show that
this capacity is APOE dependent. We show that APOE increases
the expression of IL-6 in a CD14-dependent manner, likely activat-
ing the innate immunity receptor cluster, as shown for APOA-I
(Smoak et al, 2010). While our adoptive transfer experiments
suggest that MP-derived APOE is sufficient to induce this effect (all
experiments were conducted with C57BL/6J recipients), we do not
exclude that RPE-derived APOE participates in the effect in vivo, in
particular in human AMD where RPE APOE expression was strong.
IL-6 in turn inhibited MP elimination, as a CD14- and IL-6-blocking
antibody partly reversed the elimination deficit of adoptively trans-
ferred M/s and inhibited subretinal MP accumulation in a model
of laser-induced inflammation in Cx3cr1GFP/GFP mice. While we
observe that extracellular recombinant APOE can induce IL-6, we
do not exclude the possibility that intracellular APOE participates
in the increased IL-6 secretion observed in Cx3cr1GFP/GFP MPs. IL-6
secreted from the subretinal MPs in turn downregulates FasL
transcription in RPE. Using light-induced subretinal inflammation
and adoptive transfer experiments and FasLgld and Faslpr mice, we
show that FASL/FAS signaling takes part in MP elimination.
Indeed, a pharmacological FAS agonist was able to partly reverse
the elimination deficit of adoptively transferred Cx3cr1-deficient
M/s, similar to the IL-6-blocking antibody. Interestingly, ApoE-
deficient monocytes, but not macrophages, also showed a tendency
toward increased susceptibility to FASL-induced apoptosis in vitro,
which might contribute toward the differences in clearance
observed in vivo.
The accumulation of subretinal MPs is likely the result of MP
recruitment that exceeds the MP elimination rate. In the present
study, we have concentrated on MP elimination, but we do not
suggest that increased recruitment is less important. Indeed, APOE
like APOA-I also increases CCL2 expression in MPs, and we have
previously shown the role of CCL2 in subretinal MP accumulation
(Sennlaub et al, 2013). Also, our study focused on FasL expression,
but other RPE-derived signals likely play a role in MP elimination
and non-transcriptional interactions such as proteolytic cleavage of
FASL probably participate in the mechanism.
The cross talk of APOE and APOA-I, the reverse cholesterol
transport (RCT), and innate immunity are complex. On the one
hand, excess of cholesterol and cholesterol crystals can activate
Toll-like receptors (TLR) and APOE and APOA-I can bind and
neutralize TLR ligands and inhibit the induction of inflammatory
cytokines (Azzam & Fessler, 2012). On the other hand, Smoak et al
demonstrated that APOE and APOA-I are capable of triggering
TLR2/4 signaling in the absence of TLR ligands, possibly by extract-
ing cholesterol from lipid rafts in which the CD14-containing innate
immunity receptor cluster (necessary for TLR2/4 signaling) is
located (Smoak et al, 2010). Our results using a CD14-blocking anti-
body and a recent report that subretinal MP accumulation is TLR4
◀ Figure 6. APOE promotes subretinal macrophage survival via IL-6.A Quantitative RT–PCR of FasL mRNA normalized with b-actin mRNA of 12-month-old C57BL/6 RPE/choroid plexus 3 h after subretinal injection of PBS (PBS; n = 36),
IL-6 (n = 17), and APOE3 (n = 21); calculated intraocular concentrations: 5 ng/ml and 10 lg/ml, respectively; one-way ANOVA/Dunnett post hoc test PBS versus IL-6
*P = 0.038; t-test PBS versus IL-6 *P = 0.043.
B Mouse IL-6 ELISA of supernatants from C57BL/6J peritoneal macrophages incubated for 24 h in control medium, lipid-free APOE3 (5 lg/ml), APOE3 (5 lg/ml), and
polymyxin B (25 lg/ml), heat-denatured APOE3 (dAPOE3, 5 lg/ml), APOE3 (5 lg/ml), and rat IgG1 isotype control (IgG, 100 lg/ml) or APOE3 (5 lg/ml) and rat
anti-CD14 antibody (aCD14 Ab, 100 lg/ml) or APOE3 (5 lg/ml) and rat anti-TLR2 antibody (aTLR2 Ab, 100 lg/ml) (n = 5–6/group; one-way ANOVA/Bonferroni
multi-comparison tests: APOE3 versus CTL *P < 0.0001; dAPOE3 versus APOE3 #P < 0.0001; APOE3 IgG versus CTL P < 0.0001; APOE3 IgG versus APOE3 aCD14 Ab
§P < 0.0001; APOE3 IgG versus APOE3 aTLR2 Ab ++P <0.0001. Mann–Whitney U-test: APOE3 versus CTL *P = 0.0043; dAPOE3 versus APOE3 #P = 0.0117; APOE3 IgG
versus CTL P = 0.0080; APOE3 IgG versus APOE3 aCD14 Ab §P = 0.0117; APOE3 IgG versus APOE3 aTLR2 Ab ++P = 0.0079. The experiment was repeated twice with
similar results).
C Quantitative RT–PCR of IL-6 mRNA normalized with S26 mRNA of C57BL/6J and Cx3cr1GFP/GFP, and Cx3cr1GFP/GFP ApoE/ peritoneal macrophages cultured for 24 h
with CX3CL1 (n = 5 per group, one-way ANOVA/Bonferroni post hoc multi-comparison tests: C57BL/6J versus Cx3cr1GFP/GFP *P < 0.0001 and Cx3cr1GFP/GFP versus
Cx3cr1GFP/GFP ApoE/ ‡P < 0.0001. Mann–Whitney U-test: C57BL/6J versus Cx3cr1GFP/GFP *P = 0.0079 and Cx3cr1GFP/GFP versus Cx3cr1GFP/GFP ApoE/ ‡P = 0.0079. The
experiment was repeated twice with similar results.).
D, E Orthogonal and lateral Z-stack projection of IL-6 (D, red), IBA-1+ (E, green), and phalloidin (E, blue) of IBA+ mononuclear phagocytes adjacent to the phalloidin+ RPE
of a retinal flatmount from a 12-month-old Cx3cr1GFP/GFP mouse. (Representative of three independent experiments, immunostainings omitting the primary
antibody served as negative controls).
F Quantification of subretinal CFSE+F4/80+ macrophages on RPE and retinal flatmounts 24 h after subretinal injection of C57BL/6J CFSE+ macrophages into C57BL/6J
with or without IL-6 (n = 15-20/group; calculated intraocular concentrations of 5 ng/ml. Mann–Whitney U-test: *P < 0.0001).
G Quantification of subretinal CFSE+F4/80+ macrophages on RPE and retinal flatmounts 24 h after subretinal injection of Cx3cr1GFP/GFPCFSE+M/s into C57BL/6J with
control (IgG, n = 16) or anti-IL-6 antibody (aIL-6 Ab, n = 8; calculated intraocular concentrations 5 lg/ml; per group. Mann–Whitney U-test: *P = 0.0036).
H Graphical summary.
I, J 7 day laser-injured IBA-1 (green) and CD102 (red) double-stained RPE flatmounts of control IgG- (I) and anti-IL-6-treated (J) Cx3cr1GFP/GFP mice.
K Quantification of subretinal IBA-1+ mononuclear phagocytes/impact localized on the lesion surrounding RPE of Cx3cr1GFP/GFP mice treated with control IgG, IL-6-, or
CD14-blocking antibodies (calculated intraocular concentration 5 lg/ml; n = 13–14/group, one-way ANOVA/Dunnett’s post hoc tests of IgG versus any other group
*P < 0.001. Mann–Whitney U-test IgG versus anti-IL-6 *P = 0.0021; IgG versus anti CD14 *P = 0.0028).
Data information: All primary cells were prepared from male mice; all recipient C57BL/6J mice were male; ONL: outer nuclear layer; OS: outer segments; RPE: retinal
pigment epithelium. Scale bars: 20 lm (D, E); 50 lm (I, J).
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dependent in a retinal degeneration model (Kohno et al, 2013) back
the notion that TLR signaling is involved in the alteration of the
immunosuppressive environment. The involvement of reverse
cholesterol transport (RCT) in AMD might also be supported by the
recent observation that APOA-I levels are elevated in the vitreous of
AMD patients (Koss et al, 2014). Furthermore, a polymorphism of
the ATP binding cassette transporter 1 (ABCA1, associated with low
HDL and therefore possibly impaired RCT) has recently been shown
to be protective against advanced AMD (Chen et al, 2010). More-
over, IL-6 levels are associated with early AMD incidence (Klein
et al, 2014) and late AMD (Seddon et al, 2005; Klein et al, 2008)
and might participate in the weakening of RPE immunosuppression
in AMD.
In vitro, the RPE has been shown to secrete APOE preferentially
to its basal side (Ishida et al, 2004). Our immunohistochemical
localization to the basal side of the RPE in healthy human donor
tissue might suggest that this is also the case in vivo. Interestingly,
this polarization of the APOE signal was lost in GA donor tissue,
where a strong APOE signal was observed throughout the RPE cells
adjacent to the lesion. Apical APOE release from RPE into the subre-
tinal space might participate in increasing its subretinal concentra-
tion in addition to APOE released from subretinal MPs.
It has been suggested that a lack of APOE participates in both the
accumulation of lipids and the drusen formation (Ong et al, 2001;
Malek et al, 2005; Johnson et al, 2011). Indeed, ApoE/- and
APOE4 mice fed on a high-fat diet develop lipid accumulations in
the Bruch’s membrane, which has been proposed as similar to early
AMD (Ong et al, 2001; Malek et al, 2005). While these observations
might apply to early AMD, they are unlikely to play a role in late
AMD in which increased APOE immunoreactivity is observed (Klaver
et al, 1998; Anderson et al, 2001) and in which the APOE4-allele
plays a protective role (McKay et al, 2011).
Taken together, the results of our study describe a new cellular
and molecular mechanism that may participate in the weakened
subretinal immunosuppression and chronic inflammation of AMD.
Although we have detected this mechanism in mice, increased
APOA-I levels in the vitreous of AMD patients (Koss et al, 2014)
and elevated IL-6 levels with AMD suggest that a similar mecha-
nism is at work in human AMD patients. In the future, the inhibi-
tion of IL-6 and/or the restoration of RPE immunosuppression
might be employed to control pathologic subretinal inflammation
in AMD.
Materials and Methods
APOE, IBA-1, and CD18 immunohistochemistry on donor samples
Donor eyes with a known history of AMD and controls were
collected through the Minnesota Lions Eye bank. Informed consent
was obtained for all donor eyes by the Minnesota Lions Eye bank,
and the experiments conformed to the principles set out in the
WMA Declaration of Helsinki. Postmortem fundus photographs
were taken, and the posterior segment was fixed 4 h in 4% PFA,
transported in PBS, dissected, imbedded in paraffin, and sectioned
(five control maculae; five GA donor maculae). Donors gave
informed consent in accordance with the eye bank’s ethics commit-
tee. Five tonsillectomy surgical samples, removed for recurrent
acute tonsillitis, were recuperated from tonsillectomies at the Fonda-
tion Rothschild and then fixed and sectioned in the same way. For
flatmount immunohistochemistry, donor eyes with visible atrophic
areas (five eyes), visible large drusen on RPE flatmounts (five eyes),
and controls (three eyes) were dissected into approximately
5 × 5 mm tissue parts, and immunohistochemistry was performed
on submerged samples. APOE (M068-3 mouse anti-human, citrate
buffer heat antigen retrieval for paraffin sections, MBL), IBA-1 (rab-
bit anti-human, citrate buffer heat antigen retrieval, Wako Chemi-
cals), and CD18 (MCA503, rat anti-human, citrate buffer heat
antigen retrieval, Abd Serotec) immunohistochemical analyses were
performed using appropriate fluorescent or alkaline phosphatase-
coupled secondary antibodies (Molecular Probe) using a Fast Red
substrate kit (Sigma).
Animals
Wild-type and Cx3cr1GFP/GFP, ApoE/, Faslpr, and FasLgld were
purchased (Charles River Laboratories, Jackson laboratories), and
Cx3cr1GFP/GFP ApoE/ mice were generated. All mice were negative
for the Crb1rd8, Pde6brd1, and Gnat2cpfl3 mutations. Mice were
housed in the animal facility under specific pathogen-free condition,
in a 12/12 h light/dark (100–500 lx) cycle with water and normal
diet food available ad libitum. All experimental protocols and proce-
dures were approved by the local animal care ethics committee
‘Comite´ d’e´thique en expe´rimentation animale Charles Darwin’
(N° p3/2008/54).
Light challenge and laser injury model
Two- to four-month-old mice were adapted to darkness for 6 h,
and pupils dilated and exposed to green LED light (starting at
2AM, 4,500 lx, JP Vezon equipments) for 4 days as previously
described (Sennlaub et al, 2013). Laser coagulations were
performed with a 532-nm ophthalmological laser mounted on an
operating microscope (Vitra Laser, 532 nm, 450 mW, 50 ms and
250 lm). Intravitreal injections of 2 ll of PBS, isotype control rat
IgG1, rat anti-mouse IL-6 (R&D Systems), and rat anti-mouse CD14
(BD Biosciences) were performed using glass capillaries (Eppen-
dorf) and a microinjector. The 2 ll solution of the antibodies was
injected at 50 lg/ml, corresponding to an intraocular concentration
of 5 lg/ml assuming their dilution by approximately 1/10 in the
intra-ocular volume.
Immunohistochemistry, MP quantification, and histology
Human and murine RPE and retinal flatmounts and human and
murine sections were stained and quantified as previously described
(Sennlaub et al, 2013) using polyclonal goat anti-human APOE
(Millipore), polyclonal rabbit anti-IBA-1 (Wako), polyclonal rabbit
anti-rat FASL (Millipore), monoclonal rat anti-mouse IL-6 (R&D
Systems), AlexaFluor 555 phalloidin (Mol probes), and rat anti-
mouse CD102 (clone 3C4, BD Biosciences Pharmingen) appropriate
secondary antibodies and counterstained with Hoechst if indicated.
Preparations were observed with fluorescence microscope
(DM5500, Leica) or a FV1000 (Olympus) confocal microscope.
Histology of mice eyes and photoreceptor quantification were
performed as previously described (Sennlaub et al, 2013).
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Cell preparations and cell culture
Resident and thioglycollate-elicited peritoneal cells, peritoneal
macrophages, bone marrow-derived monocytes, brain microglial cell,
and photoreceptor outer segment (POS) isolation, and MP-retinal
explant co-cultures (all in serum-free X-VIVO 15 medium) were
performed as previously described (Sennlaub et al, 2013). In specific
experiments, cells were stimulated with recombinant human CX3CL1
or APOE3 (5 lg/ml, Leinco Technologies), APOE3 (5 lg/ml) with
polymyxin B (25 lg/ml, Calbiochem), heat-denatured APOE3 (5 lg/ml,
95°C, 90 min), rat anti-IgG isotype control (100 lg/ml, R&D), rat
anti-mouse CD14 (100 lg/ml, R&D), mouse anti-mouse TLR2
(100 lg/ml, Invivogen), and POS prepared as previously described
(Molday et al, 1987). For in vitro apoptosis experiments, 100,000
Mos or M/s of the different genotypes were cultured for 24 h with
or without MegaFasL (1 ng/ml, AdipoGen). TUNEL staining (In Situ
Cell Death Detection Kit, Roche Diagnostics) was performed according to
the manufacturer’s instructions; TUNEL+ and Hoechst+ nuclei were
counted automatically using the Array Scan (Thermo Fischer).
Subretinal mononuclear phagocyte cell clearance
Thioglycollate-elicited peritoneal cells (containing 70% M/s), bone
marrow-derived monocytes (~95% pure), and brain microglial cell
(~95% pure) were labeled in 10 lM CFSE (Life Technologies). Cells
were washed and resuspended in PBS. 12,000 cells (4 ll) were
injected into the subretinal space of anesthetized 2-month-old mice
using a microinjector and glass microcapillaries (Eppendorf). A hole
was pierced with the glass capillary prior to the subretinal injection
to avoid intra-ocular pressure increase and to allow retinal detach-
ment with 4 ll of solution. The subretinal injection was verified by
fundoscopy. In specific experiments, M/s were co-injected with
rhAPOE (APOE3, Leinco Technologies), rmIL-6, rat anti-mouse IL-6,
rat anti-mouse CD14, the isotype control rat IgG1 (R&D Systems), or
MegaFasL (AdipoGen). Indicated intraocular concentrations were
calculated as a dilution of 10× of the injected solution, as the
injected 4 ll corresponds to approximately 1/10 of the intraocular
volume. Eyes were enucleated after 24 h, fixed in 4% PFA, and
flatmounted. The flatmounts were double-labeled with anti-F4/80
antibody to identify CFSE+F4/80+M/s and counted on the
subretinal aspect of the retinal flatmount and the RPE/choroid
flatmount of each eye. Eyes with subretinal hemorrhages were
discarded. Double-labeled MPs in subretinal space were quantified
on RPE flatmounts and the subretinal side of retinal flatmounts.
Flow cytometry
Cytometry was performed as previously described (Camelo et al,
2012), using anti-CD11b PE, anti F4/80 Pacific Blue, or APC, strepta-
vidin APC (all from Abd Serotec). Acquisition was performed on LSRII
cytometer (BD Biosciences), and data were analyzed with FlowJo 7.9.
Western blot, reverse transcription and real-time polymerase
chain reaction, and ELISA
WB analysis was performed using a polyclonal goat anti-ApoE (Milli-
pore) and a polyclonal goat anti-Mertk (R&D) as previously
described (Houssier et al, 2008). RT–PCRs using SYBR Green (Life
Technologies) and ELISAs using mouse IL-6 DuoSet (R&D Systems)
were performed as previously described (Sennlaub et al, 2013).
Terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) on flatmounts
4% PFA-fixed retinal flatmounts were post-fixed in frozen metha-
nol/ acetic acid (2:1) for 30 min and washed in PBS. Flatmounts
were incubated overnight at 4°C with the terminal transferase and
the supplied buffer (In Situ Cell Death Detection Kit, Roche Diagnos-
tics). Flatmounts were then incubated at 37°C for 90 min, and the
reaction was stopped by washing with PBS. Nuclei were counter-
stained with Hoechst (Sigma-Aldrich). Flatmounts images were
captured with a DM5500 microscope (Leica).
Statistical analysis
Sample sizes for our experiments were determined according to
our previous studies and a pilot study concerning subretinal MP
injections. The pilot study revealed that severe hemorrhage
secondary to subretinal injection interferes with MP clearance and
was used as exclusion criteria. Graph Pad Prism 6 (GraphPad Soft-
ware) was used for data analysis and graphic representation. All
The paper explained
Problem
Physiologically, the subretinal space, located between the retinal
pigment epithelium (RPE) and the photoreceptors, is a zone of
immune privilege mediated in part by immunosuppressive RPE signals
that induce apoptosis of leukocytes. In healthy subjects, this space is
therefore devoid of all leukocytes, including mononuclear phagocytes
(MP), a family of cells that include microglial cells, monocytes, and
macrophages among others. Nevertheless, MPs accumulate subretinal-
ly in contact with the RPE in age-related macular degeneration (AMD)
and likely participate in neurodegeneration and neovascularization in
the disease. The reasons for the breakdown of subretinal immuno-
suppression and accumulation of MPs in AMD remain unknown.
Results
This study shows that subretinal MPs in AMD express high amounts
of apolipoprotein E (APOE), a lipoprotein that plays a crucial role in
reverse cholesterol transport. Using Cx3cr1/ mice that accumulate
subretinal MPs with age and after light- or laser-induced stress, we
demonstrate that APOE prolongs subretinal MP survival and is neces-
sary for subretinal MP accumulation. We demonstrate that increased
APOE induces IL-6 in MPs, via the activation of the TLR2-CD14-
dependent innate immune receptor cluster. IL-6 in turn represses RPE
FasL expression, prolongs subretinal MP survival, and promotes
chronic subretinal inflammation.
Impact
Taken together, the results of our study describe a new cellular and
molecular mechanism that explains the weakening of subretinal
immunosuppression and consequently participates in chronic inflam-
mation in AMD. Although detected in mice, the association of the
APOE isoform 2, which is associated with higher APOE concentrations
and elevated IL-6 serum levels in AMD, suggests that a similar mecha-
nism is at work in human AMD patients. In future, the inhibition of
IL-6 and the restoration of RPE immunosuppression could be used to
control pathologic subretinal inflammation in AMD.
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values are reported as mean SEM. Statistical analysis was
performed by one-way ANOVA followed by Bonferroni or
Dunnett’s post-test (multiple comparison) or Mann–Whitney U-test
(2-group experiments) for comparison among means depending on
the experimental design. The n and P-values are indicated in the
figure legends.
Supplementary information for this article is available online:
http://embomolmed.embopress.org
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